Smith & Nephew PLC

GB

SN

Health Care

24.36 ₽

Current price

Sell
24.36 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    327 / 663

  • Position in country

    1324 / 1912

  • Return on Assets, %

    2.6

    -11.9

  • Net income margin, %

    3.2

    -12.5

  • EBITDA margin, %

    24.5

    -2.5

  • Debt to Equity, %

    59.1

    15

  • Intangible assets and goodwill, %

    41

    3.9

  • Revenue CAGR 3Y, %

    6.7

    12.6

  • Revenue Y, % chg

    6.4

    4.6

  • P/E

    39.4

    28.3

  • P/BV

    1.9

    1.7

  • P/S

    1.8

    3.7

  • EV/S

    2.4

    3.2

  • EV/EBITDA

    10.2

    -0.2

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    36.7

    66.5

  • Forward P/E

    19.7

    19.2

  • Dividend Yield, %

    3.1

    1.8

  • Forward Dividend Yield, %

    1.7

    0.2

  • Expected dividend per share

    0.4

    0

  • Payout Ratio, %

    124.3

    17.3

  • Dividend Ex Date

    2024-04-01

Get an analytical review of this company

Competitors

Ranks

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Medtronic PLC

    00%

  • Edwards Lifesciences Corp

    00%

  • Siemens Healthineers AG

    00%

  • Abbott Laboratories

    00%

  • Smith & Nephew PLC

    00%

  • LivaNova PLC

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United Kingdom

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    10547.1

  • Ticker

    SNN.N

  • ISIN

    US83175M2052

  • IPO date

    1951-08-13

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-11

  • Date fact. publication of reports

    2023-12-31

Company Description

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: